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Abstract 
The rate of RNA Polymerase II (RNAPII) elongation has an important role in 
the control of Alternative splicing (AS); however, the in vivo consequences of an 
altered elongation rate are unknown. Here, we generated mouse embryonic stem 
cells (ESCs) knocked-in for a slow elongating form of RNAPII. We show that a 
reduced transcriptional elongation rate results in early embryonic lethality in 
mice. Focusing on neuronal differentiation as a model, we observed that slow 
elongation impairs development of the neural lineage from ESCs, which is 
accompanied by changes in AS and in gene expression along this pathway. In 
particular, we found a crucial role for RNAPII elongation rate in transcription 
and splicing of long neuronal genes involved in synapse signaling. The impact of 
the kinetic coupling of RNAPII elongation rate with AS is more predominant in 
ESC-differentiated neurons than in pluripotent cells.  Our results demonstrate 
the requirement for an appropriate transcriptional elongation rate to ensure 
proper gene expression and to regulate AS during development. 
 
 
 
Keywords RNA polymerase II; transcription elongation; kinetic coupling; mouse 
model, ESCs differentiation, neurons 
 
Subject categories RNA Biology; Transcription 
                                                                                                              Maslon et al. 
 3
Introduction 
Alternative splicing (AS) is a highly regulated process that generates RNA diversity 
and is a major contributor to protein isoform diversity. Its regulation not only depends 
on the interaction of trans-acting factors with regulatory RNA cis-acting sequences 
but also on multiple layers of regulation, which include DNA methylation, chromatin 
structure and modification, and transcription (Schwartz & Ast, 2010; Lev Maor et al, 
2015; Naftelberg et al, 2015). The co-transcriptional nature of pre-mRNA splicing led 
to the suggestion that the rate of transcription elongation acts to control AS in 
mammalian cells (Beyer & Osheim, 1988; Roberts et al, 1998; Pandya-Jones & 
Black, 2009). Notably, there is a functional relationship between the transcriptional 
and the splicing machineries, as evidenced by the role of splicing factors, such as 
TCERG1, also known as CA150 (Suñé & Garcia-Blanco, 1999) and SRSF2 (Lin et al, 
2008), in stimulating transcriptional elongation. Interestingly, a role for transcription 
elongation rate influencing splicing fidelity and co-transcriptionality was also 
observed in yeast (Herzel et al, 2017; Aslanzadeh et al, 2018).  
The elongation control of transcription can be highly regulated and have a profound 
effect on gene expression. Indeed, following transcription initiation, the transition of 
RNAPII from a paused to a productive elongation stage constitutes a major rate-
limiting step in the transcription of approximately 40% of mRNA-encoding genes 
(Min et al, 2011; Vos et al, 2018a, 2018b). Furthermore, transcription elongation is 
variable, as synthesis rates can differ between genes by several-fold and these 
variations in elongation rates could be associated with different gene features and 
epigenetic modifications. 
Recent studies revisited the contribution of the kinetics of RNAPII elongation to the 
regulation of AS, giving rise to two complementary models (Bentley, 2014; 
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Naftelberg et al, 2015). The “window of opportunity” or kinetic model of AS 
regulation proposes that the rate of RNAPII elongation influences the outcome of 
alternative splicing selection. Use of a mutant form of RNAPII (C4/R749H) with a 
slower elongation rate leads to an increased (de la Mata et al, 2003) or decreased 
(Dujardin et al, 2014) inclusion of alternative cassette exons into mature mRNA. A 
complementary model, termed ‘Goldilocks’, concluded based on the study of RNAPII 
mutants with both slow and fast elongation rates, that an optimal rate of 
transcriptional elongation is required for normal co-transcriptional pre-mRNA 
splicing (Fong et al, 2014). In both models, recruitment of splicing regulators to cis-
acting RNA sequences as well as nascent RNA folding are influenced by the 
elongation rate of RNAPII (Eperon et al, 1988; Buratti & Baralle, 2004; Saldi et al, 
2018). The global impact of RNAPII elongation rate in the regulation of AS was 
confirmed with the use of drugs that inhibit RNAPII elongation (Ip et al, 2011).  
Exogenous agents also affect transcriptional coupling to AS. For instance, UV 
irradiation promotes RNAPII hyperphosphorylation with the subsequent inhibition of 
transcriptional elongation, leading to changes in AS, suggesting that transcriptional 
coupling to AS is a key feature of the DNA-damage response (Muñoz et al, 2009; 
Williamson et al, 2017). In plants, light regulates AS through the control of 
transcriptional elongation by promoting RNAPII elongation, which is negatively 
regulated in darkness (Godoy Herz et al, 2019). To date, all studies investigating the 
role of transcription elongation in pre-mRNA processing in mammalian systems have 
been confined to the use of cultured cells transfected with α-amanitin-resistant slow 
or fast RNAPII elongation mutants. Thus, the consequences of this mechanism of 
regulation in vivo and its effect on cellular differentiation and development remain 
largely unexplored. Here, we sought to address two important yet largely unexplored 
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questions. First, how does an altered transcriptional elongation rate affect gene 
expression and the control of AS and impacts on mammalian development? Secondly, 
what is the extent and the tissue/organism phenotypic consequences of the elongation 
control of AS? To answer these questions, we generated mouse embryonic stem cells 
(ESCs) knocked-in for a slow RNAPII mutant (C4/R749H). We show that an 
appropriate RNAPII elongation rate is essential for proper mouse development. We 
observed that a reduced elongation rate results in major changes in splicing and in 
gene expression in pluripotent ESCs and along the pathway of neuronal 
differentiation. The impact of the kinetic coupling of RNAPII elongation rate with AS 
is more predominant in ESC-differentiated neurons than in pluripotent cells, as it is 
essential for the expression and splicing of neuron-specific genes involved in synapse 
signaling.  
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Results 
Generation of a slow RNAPII knock-in mutant mouse ES cells 
To address the consequences of an altered transcriptional elongation rate for gene 
expression and for the kinetic control of AS, we set out to generate an in vivo model 
of a slow RNAPII by introducing a heterozygous or homozygous R749H mutation 
into the endogenous Polr2a in mouse ESCs. This mutation is equivalent to the C4 
point mutation identified in the Drosophila pol II largest subunit, which confers a 
lower elongation rate, is less capable of transcribing through natural elongation 
blocks, and causes non-lethal developmental defects in the heterozygous state 
(Coulter & Greenleaf, 1985; Mortin et al, 1988; Chen et al, 1996). Gene targeting in 
mouse ESCs was achieved by rounds of homologous recombination to introduce the 
R749H mutation into each allele of Polr2a to generate heterozygous and homozygous 
ESCs (Fig 1A, henceforth referred to as WT/slow and slow/slow ESCs). We verified 
the correct targeting by PCR of genomic DNA isolated from these ESCs and a 
diagnostic XhoI digest (Fig 1B). Ion Torrent sequencing of overlapping PCR products 
from ESC genomic DNA encompassing a ~14kb region around the R749H mutation 
confirmed that the heterozygous WT/slow and homozygous slow/slow ESCs 
contained no genomic re-arrangements or additional mutations in this region relative 
to the parental WT/WT ESCs. We verified the expression of mutant RNAPII in these 
cells by cDNA sequencing (Fig 1C) and using allele-specific RT-qPCR (Fig 1D). 
  
Slow transcription elongation hinders early mouse development  
The WT/slow ESCs were used to generate a slow RNAPII knock-in mouse model by 
injection into C57BL/6 blastocysts. We obtained mouse chimeras from these 
injections; however, no germline transmission was observed upon breeding 8 male 
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animals with at least 30% coat color chimerism to C57BL/6 females. These chimeric 
animals either sired only host blastocyst-derived offspring or were infertile and lacked 
sperm in the epididymis. As a test, breeding of 3-4 male chimeras is typically 
sufficient to detect germline transmission (BVAAWF/FRAME/RSPCA/UFAW Joint 
Working Group on Refinement, 2003). This indicates that ESCs with a heterozygous 
slow RNAPII appear to be unable to functionally contribute to spermatogenesis. To 
investigate the developmental consequences of the Polr2a R749H mutation further, 
we set out to generate R749H mutant mice using CRISPR/Cas9 (Fig 2A). Specific 
single guide RNAs (sgRNAs) against Polr2a were microinjected into (C57BL/6 x 
CBA) F2 zygotes along with the Cas9 mRNA and an oligonucleotide repair template 
containing the R749H mutation (“slow oligo”) and subsequently embryos were 
transferred into pseudopregnant recipient mice at the two-cell stage. No live-borne 
mice were obtained containing homozygous or even heterozygous mutations in the 
Polr2a locus among the 47 pups (Fig 2B). To rule out inefficient induction of double-
strand DNA breaks (DSBs) by sgRNAs, or inefficient oligonucleotide-mediated repair 
at this locus, we co-injected the same pair of sgRNAs with a repair template mixture 
containing a 1:1 ratio of a slow oligo and a silent oligo, the latter being a repair 
template containing silent mutations. Again, we could not detect the slow mutation in 
any of the 51 pups born; however, we obtained two homozygotes and four 
heterozygotes as a result of repair with silent oligo (Fig 2C). Taken together, the ESC 
chimeras and the CRISPR/Cas9 microinjections suggest that even heterozygosity for 
Polr2a R749H causes developmental defects in mice. Next, we investigated at what 
stage the Polr2a R749H mutation caused embryonic lethality. We microinjected slow 
oligo along with guide RNAs into zygotes, cultured the zygotes in vitro for 3 days, 
and analyzed the resulting embryos at the late morula/blastocyst stage. We found 
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several slow heterozygous embryos and only 1 homozygous embryo, revealing that 
the R749H mutation was tolerated at the pre-implantation stage (Figs 2B and C). 
However, when microinjected zygotes were transferred to pseudopregnant recipient 
females at the 2-cell stage to allow them to implant and develop further, only one 
heterozygous and no homozygous slow mutations were found in mid-gestation 
embryos at E9.5-E11.5 (Fig 2C). Thus, we conclude that the Polr2A R749H mutation 
causes early embryonic lethality. 
 
The R749H mutation decreases the transcription elongation rate in mouse ESCs 
We analyzed the effect of the slow RNAPII mutation in ESCs using 5,6-
dichlorobenzimidazole 1-beta-D-ribofuranoside (DRB) to measure RNAPII 
transcriptional elongation rates (Singh & Padgett, 2009). DRB inhibits P-TEFb–
dependent phosphorylation of the transcription elongation factor Spt5 and of Serine 2 
in the carboxy-terminal domain (CTD) of RNAPII. Thus, newly initiated RNAPII 
cannot progress to the elongation phase; however, upon DRB removal, all initiated 
polymerases are released, and the appearance of selected intron-exon junctions can be 
monitored by qRT-PCR in a time-dependent manner. We monitored how transcription 
proceeded through the Itpr1 and Utrophin genes, following DRB removal. 
Transcription over the first exon-intron junctions did not differ between the wild-type 
(WT) and mutant cell lines (Fig EV1, Exon 1-Intron 1 panels). However, appreciable 
pre-mRNA levels at the more downstream exon-intron junctions were detected earlier 
in WT than in slow/slow cells. For example, the appearance of an exon-intron 
junction 133kb downstream from the Itpr1 transcription start site was detected at 40 
min post-DRB release for the WT, as compared to 90 min for the mutant RNAPII (Fig 
EV1A, see Exon 5-Intron 5 panel). An overall mean elongation rate across Itpr1 and 
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Utrophin was estimated to be 3.3 kb/min and 5.6 kb/min, respectively in WT cells, as 
compared to 1.5 kb/min and 1 kb/min in slow/slow cells. We also measured overall 
transcription using a reversible DRB block followed by incubation with medium 
containing tritiated (3H)-Uridine. Time-resolved accumulation of newly made RNA, 
as measured by the incorporation of 3H-Uridine, was attenuated in slow/slow in 
comparison to WT ESCs (Fig EV1B). We also found that nuclear extracts isolated 
from slow/slow cells were less efficient in driving the production of a run-off 
transcript from the artificial DNA template (Fig EV1C). These results are in 
agreement with the previous observation that the R749H mutation in RNAPII leads to 
approximately a two-fold decrease in the transcription elongation rate in vitro 
(Boireau et al, 2007) and that the elongation rate positively correlates with expression 
levels (Danko et al, 2013; Jonkers et al, 2014). 
 Next, we analyzed RNAPII elongation rates genome-wide using metabolic labeling 
of newly transcribed RNAs by the uridine analogue, 4-thiouridine (4sU) (Rädle et al, 
2013; Fuchs et al, 2014). Transcription was arrested with DRB for 3 h, then DRB was 
removed and cells were allowed to transcribe for 5 and 15 mins. To label the newly 
transcribed RNA, cells were pulsed with 4sU for the last 10 min of each time point 
(Fig 3A). Cells not released from transcriptional block (“0 min”) were also labeled 
with 4sU. Following biotinylation and purification, 4sU-labeled RNAs were subjected 
to deep sequencing. At time “0 min”, which corresponds to the release from DRB 
inhibition, the vast majority of reads were observed over a narrow area near the 
promoter (Fig 3B, black line, and EV2A, top panel). As time progresses, the reads 
from nascent RNA are observed further into the gene bodies, referred to as the 
transcription “wave front” progression (Fig EV2A, wave front progression in Notch1).  
On average, we observed that in WT cells, RNAPII had progressed approximately 11 
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kb into the gene at 5 min and up to 35.8 kb after 15 min after DRB removal. By 
contrast, in slow/slow cells the transcription wave-fronts reached only 8.6 kb and 26.7 
kb at 5- and 15-min time points, respectively (Figs EV2B and 3B). Genome-wide, we 
observed an average elongation rate of 2,450 bases/min in wild-type cells, but reduced 
rates of 1,780 bases/min in slow/slow cells (Figs 3B, D). Previous work suggests that 
the speed of RNAPII differs between genes (Jonkers et al, 2014; Danko et al, 2013). 
The density plot of reported elongation rates demonstrates that the dynamic range of 
transcription rates is narrower in slow RNAPII cells, whilst in wild-type cells it seems 
to be bimodal revealing a population of RNAPII transcribing at higher rates (Fig 3C). 
Indeed, most genes have a lower elongation rate in slow/slow cells in comparison to 
wild-type cells (e.g. Ern1 is transcribed at 4.2kb/min and 1.9kb/min, in wild type and 
slow/slow cells, respectively (Table EV1). Interestingly, there are examples of genes 
that are transcribed faster in slow/slow cells. It is possible that a slower elongation 
rate might lead to a longer residence time, allowing more time for positive factors to 
bind and/or stimulate RNAPII and consequently lead to overall higher transcription 
rates for these genes. Finally, there is a positive correlation between elongation rate 
and expression levels (Fig EV2C), indicating that on average, highly expressed genes 
have faster elongation rates in agreement with previous reports (Jonkers et al, 2014; 
Danko et al, 2013).  Overall, these data validate previous results obtained in cultured 
cells transfected with an α-amanitin-resistant RNAPII harboring the C4 mutation (de 
la Mata et al, 2003; Fong et al, 2014) and confirms that the endogenous knock-in of a 
slow RNAPII mutation affects negatively the transcriptional elongation rate in mouse 
ESCs.  
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Role of transcriptional elongation during neural differentiation 
To assess whether a differential transcription elongation rate affects ESC 
differentiation, we exploited an in vitro model of neuronal development. During 
embryonic development, different pathways control self-renewal and differentiation 
capacity of neural progenitors (Doe, 2008; Aguirre et al, 2010). ESCs can 
differentiate into multipotent Sox1 and Nestin-positive neuronal progenitor cells 
(NPCs) in a serum-free adherent monolayer culture (Ying et al, 2003; Conti et al, 
2005) (Fig 4A). The ESC-derived NPCs can then be used to generate neural stem 
cells (NSCs) by allowing these cells to form floating aggregates (AGGs) in 
epidermal/fibroblast growth factor 2 (EGF/FGF2)-containing medium that then 
outgrow a population of bipolar, self-renewing and multipotent Neural stem cells 
(NSCs) when plated in adherent conditions (Fig 4A). Alternatively, NPCs can be 
differentiated into all three neural lineages. For example, when cultured adherently on 
poly-ornithine/laminin in media containing cAMP and ascorbic acid, they 
differentiate into Tuj1+ immature neuronal cells and further into Map2-positive 
mature post-mitotic neurons. 
 We induced differentiation of WT ESCs and slow/slow ESCs into NPCs. We found 
that both wild-type and slow/slow cells generated Sox1, Pax6 and Nestin-positive 
NPCs (Fig 4B), however, we also observed decreased proliferation or compromised 
differentiation potential of slow/slow cells (see Methods). We next tested if we could 
generate NSCs from slow/slow ESC-derived NPCs. Interestingly, we found that 
despite obtaining neural AGGs (Fig 4C), slow/slow NSCs could not be maintained in 
EGF/FGF2 proliferating conditions (Fig 4D). Instead, following a few passages we 
noted the appearance of flattened differentiated cells in the slow/slow cultures, and 
subsequently we observed overwhelming cellular death. Strikingly, amongst some of 
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the remaining Nestin-positive cells in these slow/slow cultures, we observed 
promiscuous differentiation to Tuj1+ cells (Fig 4D). These results suggest that the 
balance between maintenance of the self-renewing cell state and differentiation might 
be perturbed in slow/slow NSCs.  
 Indeed, Gene Ontology (GO) analysis revealed that those genes upregulated in 
slow/slow NPCs and in aggregates (AGG) were involved in neuronal functions (Table 
EV2 and Appendix Fig S1A), which might explain some of the phenotypes observed 
in slow/slow NSCs (Fig 4). We observed upregulation of Ascl1, Nr2f1, Crabp2 and 
Nr6a1 genes (Appendix Fig S1B) in slow/slow NPCs and AGGs. Their 
overexpression has been previously shown to suppress proliferation of progenitor 
cells, induce neurogenesis and neuronal maturation (Chanda et al, 2014; Gkikas et al, 
2017), and could explain the premature differentiation observed in slow/slow NSCs. 
In parallel, we observed that the EGF receptor (EGFR) was two-fold downregulated 
in slow/slow NPCs (Table EV2). As EGF withdrawal causes massive cell death and 
premature differentiation observed in slow/slow NSCs (Conti et al, 2005), decreased 
expression of EGFR in slow/slow NPCs could contribute to the observed lack of their 
self-renewal in EGF/FGF2 proliferating conditions. Although the slow RNAPII allele 
appears to impair the maintenance of NSCs, the presence of differentiated Tuj1 
neurons in the NSC cultures (Fig 4D) suggests that a slow transcriptional elongation 
rate does not impair neuronal differentiation per se. Indeed, when re-plated onto poly-
ornithine/laminin coated plates, both WT and slow/slow NPCs, differentiated into 
Tuj1, Map2 and NeuN- positive neurons (Figs 4E and EV3A, B). Whereas we 
observed a robust expression of the synaptic marker (Syn1) in WT neurons, it seemed 
reduced in slow/slow neurons (Figs EV3A, B). Overall these data show that the slow 
mutation in RNAPII causes problems in the maintenance/self-renewal of NSCs but 
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appears not to interfere with neuronal differentiation per se. It also suggests that 
neurons harboring a homozygous slow mutant RNAPII might be functionally or 
developmentally different than WT neurons.  
 
Transcriptional elongation rate influences alternative splicing decisions in ESCs 
and during neural differentiation 
Next, we investigated gene expression and AS changes by RNA sequencing (RNA-
seq) analysis of poly (A)+ RNA isolated from pluripotent ESCs, NPCs and neurons. 
First, we compared alternative exons usage between wild-type and slow/slow cells 
using vast tools, which assigned a “percentage spliced in” (PSI) value to each exon. 
Analysis of AS changes revealed 75, 167 and 415 events of enhanced exon inclusion, 
comprising cassette exons and microexons, in slow/slow ESCs, NPCs and neurons, 
respectively, as compared to their WT counterparts (Fig 5A and Table EV3). We also 
observed that whereas cassette exon events did not show a bias towards increased 
exon inclusion in slow/slow ESCs or NPC cells when compared to WT cells, there 
was some tendency for an increased exon inclusion in neurons (60% of alternative 
cassette exons are more included in slow/slow neurons) (Fig 5A). By contrast, we 
found that exon skipping was enhanced relative to cassette inclusion by the slow 
RNAPII mutant, with 91 and 510 skipped cassette exons and microexons, detected in 
ESCs and NPCs, respectively. This is compatible with the current models of kinetic 
coupling, where a slow RNAPII can lead to enhanced exon inclusion if the AS event 
depends on the recruitment of positive regulators, or to exon skipping, if splicing 
inhibitors are recruited (Dujardin et al, 2014).  
 The splicing signature in slow/slow cells could be a direct result of perturbations in 
the elongation rate or be due to an indirect effect through changes in expression of 
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splicing factors and/or RNA-binding proteins (RBPs). Indeed, we found that for 
example Mbnl2 was downregulated in ESCs and NPCs, whereas Nova1 was 
downregulated in neurons (Appendix Fig S2A). We also used available datasets from 
experimental perturbations of some of these differentially expressed splicing factors 
and found alternatively spliced mRNAs that were targets of these differentially 
expressed RBPs (Appendix Fig S2B). However, there was not a significant difference 
in the proportion of such indirect events between ESCs and differentiated cells, 
suggesting that most of the events differentially identified in this study correspond to 
events directly affected by the rate of elongation of RNAPII. Importantly, the extent 
of splicing changes was much more pronounced in NPCs and fully differentiated 
neurons in comparison to ESCs (166 cassette exons and microexon events changing in 
slow/slow ESCs, as compared to 677 or 693 cassette exons and microexons changes 
observed in slow/slow NPCs and neurons, respectively, Fig 5A).  We validated a 
selected number of alternatively spliced events by RT-PCR analysis (Fig 5B and 
Appendix Fig S3). Given that the total number of detected AS events in the different 
stages of neuronal differentiation is comparable (Fig 5A, B), these results underscore 
the increased importance of kinetic coupling as differentiation progresses. A possible 
explanation for this observation is related to changes in chromatin structure during 
cell differentiation. Chromatin is reported to be more open and accessible in 
pluripotent ESCs (Gaspar-Maia et al, 2011). This differential chromatin organization 
will likely have a direct influence in the elongation rate of RNAPII (Selth et al, 2010; 
Naftelberg et al, 2015). Not only, did we observe an elevated number of affected 
exons in slow/slow neurons in comparison to slow/slow ESC, but also the number of 
splicing changes increases during differentiation to neurons, with 1,365 alternative 
splicing events detected in WT cells upon differentiation, whereas this number 
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increases to 2,252 exons in slow/slow cells (Table EV3). We examined the properties 
of elongation-rate sensitive exons, namely 5’ and 3’ splice sites strength, as well as 
the length of flanking introns and alternative exon (Yeo & Burge, 2004; Corvelo et al, 
2010) (Fig EV4A). We noted that exons that were more included in slow/slow ESCs 
had longer flanking introns (median of 2,335 and 1,546 bases in included and not-
affected exons, respectively). Consistent with the ‘window-of-opportunity’ model of 
kinetic coupling, these longer introns could contribute to a time delay significant 
enough to promote recognition and splicing of suboptimal exons in nascent 
transcripts. By contrast, exons affected in slow/slow neurons did not show such 
characteristics and seemed to be more dependent on the repertoire of expressed RBPs. 
For example, RNA maps produced for RNA-binding proteins (CISBP-RNA IUPAC 
binding motifs (Ray et al, 2013)) revealed that introns downstream of  exons skipped 
in slow/slow neurons are enriched for Nova1 binding sites (Fig EV4B) and indeed 
binding of this factor downstream of alternative exons, has been previously shown to 
enhance their exclusion (Ule et al, 2006). Conversely, we noted increased occurrence 
of Rbfox1 binding motifs in the introns downstream of exons showing more skipping 
in slow RNAPII-expressing neurons (Zhang et al, 2008). As the levels of Rbfox1 
remain the same between WT and slow/slow neurons, this observation indicates some 
functional connection between this splicing factor and kinetic coupling. 
 High-throughput RNA-seq of poly (A)+RNA revealed changes in the expression of 
several hundreds of genes in slow/slow cells, as compared to their WT counterparts 
(Appendix Figs S4A, B, and Table EV2). We, therefore, looked at whether the 
observed changes in AS are coupled to changes in the expression of corresponding 
genes. Notably, the differential splicing observed in the presence of a slow elongating 
RNAPII is generally not driven by differential gene expression (Fig EV5 A-C). The 
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only exception are some cases of intron retention, where negative correlation with the 
expression might reflect frequent coupling of intron retention to NMD (Fig EV5 A-
C). Thus, we conclude that the majority of AS changes are not merely a consequence 
of a differential gene expression between ESCs, NPCs and neurons, but rather show 
specific sensitivity to RNAPII speed during differentiation (Appendix Table S1, Fig. 
EV5). 
 
Slow transcription elongation perturbs expression of long synaptic genes 
Enrichment Map visualization of gene-sets enriched amongst downregulated and AS 
genes in slow/slow neurons revealed that they are involved in programs that are 
essential for synapse formation and synaptic signaling (Figs 6A and Appendix Fig 
S5). Indeed, genes downregulated in slow/slow neurons encode proteins involved in 
the entire life cycle of synaptic vesicles. Amongst them are: Syn1 and Syn2, which 
tether the vesicle to the actin cytoskeleton (Thomas et al, 1988), Snap25, Stx1b, 
Stxbp1, Syt1 proteins, that are involved in synaptic vesicle fusion and recycling; as 
well as neurexins (including Nrxn1 and Nrxn2) and contactin-associated proteins 
(including Cntnap2 and Cntnap3) that form the synaptic scaffolding system and are 
involved in trans-synaptic communication. Similarly to downregulated genes, 
alternative splicing events involved proteins that are important for synaptic signaling 
(Table EV4). For example, we observed increased skipping of alternative exons in 
Scrib, a gene encoding a protein involved in neurotransmitter release (Fig 5B). We 
also confirmed differential splicing of Exon 7 in Apbb2, a protein involved in 
synaptic vesicle loading (Appendix Fig S3). We noted altered splicing amongst 
members of neurexins, synaptic receptors that undergo an extensive combinatorial use 
of AS to provide molecular diversity required for the functional differentiation of 
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synapses (Table EV3) (Schreiner et al, 2014). Finally, we observed, AS events in 
proteins involved in the synaptic vesicle cycle, including both pre-synaptic and post-
synaptic space, amongst them Stx4A, Syn1, Synj1, Stx3 and many others, some of 
them resulting in premature termination codons, others changing domain structures or 
affecting ion transfer, hence all likely contributing to the function or the specificity of 
the synapse (Table EV4).  
 Interestingly, we noticed that those genes that are preferentially downregulated in 
slow/slow neurons, are significantly longer than those that were not affected or that 
are upregulated (Fig 6B, right panel). By, contrast, we found no significant change in 
the average gene length of downregulated genes in ESCs (Fig 6B, left panel). 
Notably, a slow transcriptional elongation rate reduced expression of nearly all long 
genes in neurons, with the percentage of downregulated genes in slow/slow neurons 
progressively increasing from around 40% for 10 kb genes to over 80% for extremely 
long genes (Fig 6C, right panel). Some examples of such genes include Cntnap2 (2.25 
Mb) and Nrxn1 (1.05 Mb) (Table EV2). In contrast, ESCs do not express such long 
genes (Fig 6C, left panel) and we observe a similar effect caused by a slow elongation 
across the entire range of gene lengths. From this we speculate that an optimal 
elongation rate is important to sustain transcription and splicing of particularly long 
transcripts that are required for neuronal function. Indeed, recent reports propose that 
long genes require special mechanisms to specifically maintain long-distance 
transcription. As an example, the neuronal RNA-binding protein Sfpq 
(proline/glutamine-rich, also known as PSF), has been shown to be a critical factor for 
maintaining transcriptional elongation of long genes (Patton et al, 1993; Takeuchi et 
al, 2018).  
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 Thus, we found that both downregulated as well as preferentially alternatively 
spliced genes in slow/slow ESC-derived neurons converge onto long genes that are 
involved in synaptic function. Candidate genes involved in neurodevelopmental 
diseases encode synapse proteins and are exceptionally long (Bourgeron, 2015).  We 
identified synapse signaling as a major pathway downregulated and mis-spliced in 
slow/slow neurons and found that slow RNAPII downregulated almost all long genes 
in neurons. Therefore, we further analyzed the overlap of the genes downregulated 
and differentially spliced in slow/slow neurons with available datasets for brain 
disease, including causative genes for autism and schizophrenia (SFARI). We noted 
that genes differentially expressed and spliced in slow/slow neurons significantly 
overlapped with those linked to neurological disorders, including ASD disease 
(Appendix Table S6). From these experiments, we can conclude that a reduced 
transcriptional elongation rate preferentially affects the expression and alternative 
splicing of long synaptic genes. 
 In summary, the development of a genetic system based on knock-in for a slow 
RNAPII mutation in mouse ESCs unequivocally established that an appropriate 
RNAPII elongation rate is essential for proper mouse development and for gene 
expression and its kinetic coupling with AS. Interestingly, the kinetic control of AS is 
predominantly affected in differentiated cells, suggesting that the chromatin 
environment represents an important determinant of this coupling. Altogether, our 
results provide compelling evidence that transcription elongation rates can have a 
regulatory role in the expression of genes and the regulation of their alternative 
splicing patterns during development. 
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Discussion  
A slow elongation rate causes early embryonic lethality 
We observed that a slow RNAPII mutant caused embryonic lethality even in 
heterozygosity (Fig 2). There is evidence that the transcriptional output is crucial in 
specific developmental stages associated with stem cell expansion, as evidenced by 
the their hypertranscription state (Koh et al, 2015; Percharde et al, 2017). It is 
possible that a slow elongation rate cannot sustain the high levels of mRNA 
production required at early stages of development. It was suggested that progenitor 
cells might also require hypertranscription to allow for their expansion. Similarly, loss 
of self-renewal in slow/slow NSCs could be related to the inability of cells harboring 
a slow RNAPII to maintain the required levels of transcriptional output. Initial stages 
of mouse embryonic development display a great range of cell cycle duration, from up 
to 20 h for the first cell division to 2-3 h cell cycles during gastrulation (Artus et al, 
2006) or 8 h during initial stages of murine neurogenesis (Takahashi et al, 1995). In 
this scenario, a reduced elongation rate in slow/slow mutant embryos might not allow 
efficient transcription or might delay expression of some crucial mRNAs that need to 
be expressed in these fast dividing cells. Whereas in mice both the homozygous and 
heterozygous slow mutation result in embryonic lethality (Fig 2), the C4 mutation in 
Drosophila is tolerated in heterozygosity where the flies present a mutant phenotype 
called “Ubx effect” that resembles the one seen in flies haploinsufficient for the Ubx 
protein. This was attributed to Ubx missplicing as it is one of the few Drosophila 
genes with an extremely long intron (50 kb) (de la Mata et al, 2003).  This is in 
agreement with results presented here showing that mouse genes with long introns are 
preferentially affected by a slow RNAPII in ESC-differentiated neurons. 
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Kinetic coupling is enhanced in neurons 
We found that the impact of RNAPII elongation rate on AS is predominant in ESCs-
differentiated NPCs and neurons. This is most likely caused by a distinct chromatin 
environment between pluripotent and differentiated cells having a differential impact 
on RNAPII transcriptional elongation rate, since previous evidence indicated that the 
C4 mutation is not catalytically slow, but rather less efficient in overcoming internal 
pauses (Chen et al, 1996). While chromatin is quite dispersed in E3.5, 
heterochromatin foci appear in E5.5, which corresponds to the epiblast stage 
following embryo implantation (Ahmed et al, 2010). Indeed, despite the conflicting 
literature regarding deposition of histone marks throughout differentiation (Azuara et 
al, 2006; Wen et al, 2009; Lienert et al, 2011), a large body of evidence suggests that 
chromatin undergoes dynamic changes during differentiation leading to a more 
compact environment in the differentiated state. Various mechanisms might promote 
the switch from a more open to a more close chromatin during cell differentiation, 
including an increase in repressive histone marks, a local change in nucleosome 
occupancy, or a general increase in histones levels (Fiszbein et al, 2016; Gavin et al, 
2017; Yoon et al, 2018). It was reported that the nuclei of ESCs macroscopically 
appears to contain less condensed chromatin, whereas well-defined foci of compact 
heterochromatin become evident in ESCs-derived NPCs (Meshorer et al, 2006). 
Indeed, chromatin structure can become a major impediment to transcriptional 
elongation and histone modifications can directly affect the nucleosomes, by either 
loosening or tightening DNA binding around them (Veloso et al, 2014; Jonkers & Lis, 
2015).  Moreover, exons have a negative effect on RNAPII elongation rate, which 
could be associated with exonic features, such as a higher CG content, and exon-
specific histone marks (H3K36me3 and H3K4me1) (Jonkers et al, 2014). An example 
                                                                                                              Maslon et al. 
 21
of a crosstalk between the chromatin environment an AS has been shown in the case 
of exon18 in the neural cell adhesion molecule (NCAM), where membrane 
depolarization of neuronal cells induces a local H3K9 hyperacetylation, resulting in 
exon skipping (Schor et al, 2009). Conversely, inducing a more compact chromatin 
state by transfection of siRNAs targeting the intron downstream of an alternative 
exon, promotes H3K9 and H3K27 methylation, HP1 recruitment, in turn leading to 
local roadblocks for RNAPII elongation rate and increased kinetic coupling (Alló et 
al, 2009). We speculate that the specific changes in chromatin structure during 
differentiation might create natural “roadblocks” to elongating RNAPII, which is 
further enhanced in slow RNAPII-expressing cells leading to increased kinetic 
coupling observed in NPCs and neurons derived from slow/slow cells. 
 
An appropriate elongation rate sustains expression and splicing of long genes 
involved in synapse signaling in neurons 
Slow RNAPII leads to specific downregulation of longer genes in neurons. 
Intriguingly, neurons express the largest genes amongst different cell types and many 
of these encode proteins involved in neuronal development and synapse formation. As 
such, a slow elongating RNAPII could preferentially affect transcription and splicing 
of those long genes. Dysregulation of the expression of these long genes might 
represent a mechanism underlying neurodegenerative and psychiatric disorders (King 
et al, 2013; Gabel et al, 2015). For example, loss of FUS/TLS and TDP43, genes 
linked to ALS, preferentially affects splicing of long pre-mRNAs (Lagier-Tourenne et 
al, 2012). The neuronal RBP SFPQ, which is required to sustain long-distance 
transcription elongation for longer genes (Takeuchi et al, 2018),  has a role in 
neurodegenerative diseases, including ALS, ASD and Frontotemporal lobar 
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degeneration (FTLD). The differentially expressed and alternatively spliced pre-
mRNAs in neurons are involved in synapse signaling, neurite outgrowth and axonal 
guidance. We speculate that mis-regulation of RNAPII elongation rate could have 
detrimental implication in neurodevelopment, preferentially affecting the expression 
and/or splicing of synaptic proteins, which are encoded by particularly long genes 
(Fig 6). Indeed mutations in genes involved in synaptic signaling lead to 
neurodevelopmental diseases, including Autism spectrum disorder 
(ASD)(Bourgeron, 2015). Importantly, chromatin remodeling, transcription and 
splicing genes have been identified in genetics studies of de novo mutations in autistic 
patients (De Rubeis et al, 2014). These genes encode proteins that are active during 
brain development and are important in transcription elongation, either through direct 
interaction with RNAPII or indirectly through affecting chromatin structure. 
Physiological conditions that could alter RNAPII elongation or mutations disrupting 
elongation rate control might affect preferentially the nervous system, as these cells 
express particularly long genes. This could result not only in changes in transcription 
but also affect AS patterns via kinetic coupling. These observations highlight an 
essential role for an appropriate elongation rate in gene expression and splicing 
regulation during neural development and suggest that its misregulation could 
underlie some neurological disorders.  
 In conclusion, we show that a slow elongation rate affects gene expression and AS, 
consistent with the coupling of transcription with splicing. This kinetic control of AS 
is more strongly affected as differentiation progress. Most notably, we identify 
elongation rate control as a major mechanism to sustain transcription and splicing of 
long neuronal genes involved in synapse signaling. This study provides a compelling 
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evidence that transcription elongation rates have a regulatory role in the expression of 
genes and the regulation of their AS patterns during development. 
 
 
Materials and Methods 
Ethical statement 
All applicable international, national and institutional guidelines for the care and use 
of animals were followed. Animal experiments were carried out under UK Home 
Office Project Licences PPL 60/4424 and PB0DC8431 and were approved by the 
University of Edinburgh animal welfare and ethical review body. 
 
Gene targeting in ESCs 
The bacterial artificial chromosome (BAC) bMQ420i24 containing chr11:69711833-
69860134 (mm10 assembly) of the mouse genome from 129S7/SvEvBrd ES cells 
(Adams et al, 2005) was modified to introduce the R749H mutation into exon 14 of 
Polr2a using a GalK selection cassette as described (Warming et al, 2005). A ~10.3 
kb region (chr11:69741333-69751734) of the Polr2a locus was then retrieved into the 
NotI-SpeI region of PL253 using gap repair, and a Frt-flanked neomycin resistance 
cassette from plasmid PL451  introduced into intron 12 of the gap-repaired Polr2a 
clone at position chr11:69743748-69743749 as described (Liu et al, 2003). The 
resulting targeting vector was linearized with NotI and introduced into E14 ESCs by 
electroporation (Joyner, 2000). Genomic DNAs from were screened for homologous 
recombination by PCR. The neomycin resistance cassette was then excised by 
electroporation with an Flp recombinase expression plasmid to generate WT/slow 
heterozygous ESCs. The same targeting vector was used to target the WT Pol2ra 
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allele in the WT/slow ESCs, and the neomycin resistance cassette excised using Flp 
recombinase in order to generate slow/slow ESCs. WT/WT, WT/slow and slow/slow 
ESCs were confirmed to contain forty chromosomes by karyotyping as described 
(Nagy et al, 2009). Ion Torrent sequencing of overlapping PCR products from ESC 
genomic DNA encompassing a ~14 kb region around the R749H mutation 
(chr11:69739041-69753349) was used to confirm that the WT/slow and slow/slow 
ESCs contained no genomic re-arrangements or additional mutations in this region 
relative to the parental WT/WT ESCs. Genotyping was performed using the following 
forward and reverse primers: GGGACTCCATTGCAGATTC and 
ACTCAGTGGGTGTGAGACC.  
 
Mice Chimera generation and breeding 
In order to generate mouse chimeras, WT/slow ESCs were injected into C57BL/6 host 
chimeras, as previously described (Joyner, 2000). Eight male chimaeras with at least 
30% contribution from ESCs were identified by coat colour and bred with C57BL/6 
females to test for germline transmission. 
CRISPR/Cas9 Gene Editing in Mouse Zygotes 
Complementary oligonucleotides targeting exon 14 of Polr2a were annealed and 
cloned into plasmid pX335 (Cong et al, 2013). The guide region was then amplified 
by PCR and paired guide RNAs synthesised by in vitro transcription (T7 Quick High 
Yield RNA Synthesis kit, NEB). Single stranded DNA oligonucleotides (silent oligo: 
TCATTGAGAAGGCTCATAACAATGAGCTA 
GAACCCACTCCAGGAAACACATTGAGACAAACATTTGAGAATCAAGTGA
ATCGTATTCTCAATGATGCTAGGGACAAAACTGGCTCCTCTGCACAGAAA
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TCCCTCTCTGAATATAACAACTTCAAGTCTTGGTGGTGTCTGGAGCCAAGG
GTTCCAAGATCAACATCTCC, slow oligo: TCATTGAGAAGGCTCATAACAAT 
GAGCTAGAACCCACTCCAGGAAACACATTGAGACAAACATTTGAGAATCA
AGTGAATCGTATTCTCAATGATGCTCATGACAAAACTGGCTCCTCTGCACA
GAAATCCCTCTCTGAATATAACAACTTCAAGTCTATGGTGGTGTCTGGAGC
CAAGGGTTCCAAGATCAACATCTCC) were synthesized by IDT. Gene editing 
was performed by microinjection of RNA encoding the Cas9 nickase mutant (50 
ng/µl, TriLink BioTechnologies), paired guide RNAs (each at 25 ng/µl), and 150 
ng/µl single-stranded DNA oligonucleotide repair template in (C57BL/6 x CBA) F2 
zygotes (Crichton et al, 2017), and the injected zygotes were cultured overnight in 
KSOM for subsequent transfer to the oviduct of pseudopregnant recipient females 
(Joyner, 2000), or for three days to allow analysis of morula/blastocyst stage embryos. 
CRISPR/Cas9 gene editing can generate mosaic embryos (Yen et al, 2014), but for 
simplicity embryos that were genotyped to contain both a wild-type and a mutant 
Polr2a allele were classified as heterozygotes. Genotyping was performed as above 
except for blastocysts genotyping where nested PCR was performed, using first the 
above forward and reverse primers, followed by second PCR using the following 
forward and reverse primers: GAAGGCTGGGCAGAGAAGAG and 
TCCGCTTGCCCTCTACATTC  
 
In vitro transcription assay  
Nuclear extracts were prepared, as previously described (Folco & Reed, 2014). A 
DNA construct, containing CMV promoter and encoding β−globin was linearized by 
restriction digest. In vitro transcription reactions were performed at 30°C in 25 μl 
reaction mixtures containing 375 ng DNA template, 1 μl 32P-UTP, 10 μl ESCs 
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nuclear extract, 10 mM ATP, CTP, GTP, 0.4 mM UTP, 3.2 mM MgCl2. Following 
indicated time, proteinase K was added to stop transcription. RNA was extracted and 
run on denaturing polyacrylamide gel and detected by Phosphorimager.  
 
Nascent transcription assays 
Elongation rate experiments were carried out as described (Singh & Padgett, 2009). 
Briefly, cells were treated for 4 hr with 100 μM 5,6-dichlorobenzimidazole 1-β-d-
ribofuranoside (DRB) to inhibit transcription. To restart transcription, cells were 
washed twice in war, PBS, and incubated with fresh medium. During 0-180 min 
incubation, at indicated times, cells were lysed directly in Trizol and RNA was 
extracted according to manufacturer’s recommendations. 5 μg of Total RNA were 
reverse transcribed using random hexamers and Superscript III. Pre-mRNA levels 
were measured by quantitative RT-PCR using Sybr Green Master Mix and 
Lightcycler 480 (Biorad). Primers used in the quantitative RT-PCR are available on 
request. Pre-mRNA levels were normalised to pre-mRNA levels at t=0 min. Results 
depict average of three independent experiments, ± standard error.  
 
4sU-DRBseq 
ESCs were seeded in 15-cm plates in 2i medium. At the 80-90% confluency, cells 
were treated with 100 μM DRB, in three biological replicates. Following 4 h of 
incubation, DRB-containing media was removed, cells were washed twice with warm 
PBS and placed in fresh media without DRB. 4-thiouridine (4sU) was added to 
medium at a final concentration of 1mM for 10 min before each harvest. Cells were 
lysed directly on a plate with 5 ml of Trizol at indicated transcription elongation time 
point. Total RNA was isolated as per manufacturer’s instructions. Total RNA (100–
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200 μg) was used for biotinylation and purification of 4sU-labeled nascent RNAs. 
The biotinylation reaction consisted of total RNA and EZ-Link Biotin-HPDP 
dissolved in dimethylformamide (DMF) and was performed in labeling buffer (10 
mM Tris pH 7.4, 1mM EDTA) for 2 h with rotation at room temperature. Unbound 
Biotin-HPDP was removed by chloroform/isoamylalcohol (24:1) extraction in 
MaXtract tubes (Qiagen). RNA was precipitated with 10th volume of 5M NaCl and 1 
volume of isopropanol. Following one wash in 80% ethanol, the RNA pellet was left 
to dry and resuspended in 100 μl RNase-free water. Biotinylated RNA was purified 
using μMacs Streptavidin kit. Specifically, 100 μl of beads per 100 μg of RNA was 
incubated with rotation for 15 min, and then washed three times with washing buffer 
(100 mM Tris pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween20) at 65°C, followed 
by three washes at room temperature. RNA was eluted twice using 100 mM DTT and 
recovered using RNeasy MinElute Cleanup column (Qiagen) according to 
instructions. cDNA libraries were prepared using NEB Next Ultra Directional RNA 
Library Prep Kit according to the manufacturer’s instructions. Libraries were pooled 
and sequenced on an Illumina HiSeq 4000 system. All reads were aligned to the 
mouse reference genome (mm10) using bowtie 2 aligner (Langmead et al, 2009) and 
only those reads that mapped uniquely to the genome, but not to rRNA, were 
considered. A genome-wide binned profile of the nascent RNA and the 
transcription wave end were determined using previously developed methods and 
published software (Fuchs et al, 2015, 2014). 
 
Cell differentiation 
ESCs were tested for mycoplasma contamination. ESCs were cultured under feeder-
free conditions in GMEM medium supplemented with 10% fetal calf serum, NEAA, 
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β-mercaptoethanol, sodium pyruvate, L-glutamine and 100 U/ml recombinant 
leukaemia inhibitory factor (LIF) on gelatin-coated tissue culture plastic. Before 
differentiation, cells were freshly defrosted in standard medium and then passaged for 
2 passages in 2i medium (1:1 Neurobasal and DMEM/F12, supplemented with 0.5X 
N2, 0.5x B27, 0.05% BSA, 1μM 0325901, 3μM CHIR99021, 2mM L-glutamine, 
0.15mM monothioglycerol, 100U/ml LIF). 
 
Neuroectodermal specification 
One day prior to induction of differentiation cells were seeded at high density in 2i 
medium. The following day, cells were detached using accutase, resuspended in 
N2B27 media (1:1 Neurobasal and DMEM/F12, supplemented with 0.5X N2, 0.5x 
B27, 0.1 mM β-mercaptoethanol, 0.2 mM L-glutamine), counted and plated at the 
appropriated density onto either 15 cm plates or 6 well plates that have been coated 
with a 0.1% gelatin solution. Culture medium was changed every second day. The 
differentiation potential is greatly influenced by the initial plating density and was 
previously established to be optimal at approximately 10,000 cells per cm2, which is 
what we observed with the differentiation of WT ESCs. On the contrary, we observed 
increased cell death at plating densities below 30,000 cells per cm2 for slow/slow 
cells, suggesting decreased proliferation or compromised differentiation potential of 
these cells. 
 
Deriving NS cells 
For derivation of neural stem cells at day 7 of differentiation, cultures were detached 
using accutase, 2-3 x 106 cells were re-plated into an uncoated T75 flask in NS 
expansion media, comprising DMEM/F12 medium supplemented with 2mM L-
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glutamine, 0.5x N2, B27, glucose, BSA, Hepes and 10ng/ml of both mouse EGF 
(Peprotech) and human FGF-2 (Peprotech). Within 2-3 days, thousands of cell 
aggregates formed in suspension culture and were harvested by centrifugation at 700 
rpm for 1 min. They were then re-plated onto a laminin coated T75 flask. After few 
days, cell aggregates attached to the flask and outgrew with NS cell.  
 
Differentiation to neurons 
For neuronal generation and maturation at day 7 of differentiation, cultures were 
detached using accutase, replated onto poly-l-ornithine/laminin (100 μg/ml and 
10 μg/ml, respectively, Sigma–Aldrich) coated surfaces at 1.5-2 x 104 cells/ cm2 in 
N2B27 medium containing 0.2mM ascorbic acid and 0.25 mM cAMP. Cells were 
grown for the additional 14 days, with 80% media exchange every second day.   
 
RNA isolation and RT-qPCR 
RNA was isolated using TRIzol or RNAeasy following the manufacturer’s protocol. 
RNA was then treated with Dnase (Ambion) and transcribed to cDNA using First-
Strand Synthesis System from Roche. This was followed by SybrGreen detection 
system (Lightcycler 2x SybrGreen Mix, Roche).  
 
RNA purification and RNA-Seq analysis 
RNA-sequencing was carried out on RNA extracted from WT/WT and slow/slow 
ESCs, ESC-derived NPCs at day 7 of differentiation and ESC-derived neurons at day 
21 of differentiation. RNA was purified using RNeasy kit from three independent 
differentiation experiments. RNA-seq libraries were generated from Poly(A)+ mRNA 
using TrueSeq protocol and sequenced using the Illumina Hi-Seq 4000 machine 
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(Edinburgh Genomics) to generate 75 bases, paired-end reads. Reads were mapped to 
the mouse (mm9) genome. AS analysis of RNA-Seq data was performed with vast-
tools version 1 (Tapial et al, 2017). From the primary output, events with poor 
coverage or junction balance were filtered out (vast-tools quality score 3 other than 
SOK/OK/LOW for cassette exon [CE], microexon [MIC], and alternative 5´ or 3´ 
splice site [Alt5/3] events or coverage less than 15 reads for intron retention [IR] 
events; score 4 other than OK/B1 for CE and MIC events and score 5 of less than 0.05 
for IR events). Differential AS was scored using vast-tool's diff module requiring 
p(|dPSI| > 0) > 0.05 and a point estimate of |dPSI| > 10. Gene expression was analysed 
based on raw read counts per gene from vast-tools using the glm stream of the R 
package edgeR. Genes with an FDR < 0.05 were considered differentially expressed. 
Clustering of the samples shows very good correlation between results obtained in the 
three independent experiments (Appendix Fig S6). 
 
Networks. The GO network for the genes misregulated in cells harboring slow 
RNAPII was built using Enrichment Map (Merico et al, 2010) in Cytoscape 3.3.1 
(Shannon et al, 2003) with the following parameters: p-value cut-off =0.001; FDR Q 
value cut-off =0.01; Jaccard+Overlap Combined option, with cut-off = 0.375; 
Combined Constant =0.5. Enriched functional terms were obtained from g:profiler or 
by GSEA for GO_BP and KEGG pathways. g:profiler was employed for the analysis 
of GO enrichment during neuronal differentiation. 
 
Statistics. To determine statistical significance, unpaired t-tests were used to compare 
between two groups, unless otherwise indicated. The mean ± the standard error of the 
mean (SEM) is reported in the figures as indicated. Statistical significance was set 
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at P<0.05. All in vitro experiments were repeated three times and several litters were 
analysed animals for in vivo studies. Fisher’s exact test was used to determine the 
significance in animal studies.  
 
Data Availability 
The accession number for the RNA-seq and 4sU_DRB-seq data is GSE127741.  
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Key reagents table 
 
REAGENT MANUFACTURER CATALOG NUMBER 
Antibodies 
Tuj1 BioLegend 801213 
Map2 Millipore MAB3418 
RNAPII (8WG16) Abcam ab817 
Syn1 Novus Biologicals NB300-104 
Tubulin Sigma T9026
NeuN Abcam Ab177487 
Nestin Abcam Ab24692
Chemicals 
5,6-dichlorobenzimidazole 1-
β-d-ribofuranoside (DRB) 
Sigma-Aldrich D1916 
4-thiouridine Sigma-Aldrich T4509
EZ-Link biotin HPDP Thermo Scientific 21341
Dimethylformamide Thermo Scientific 20673
No-Weigh dithiothreitol    
(DTT) microtubes 
Thermo Scientific 20291 
Cell culture reagents, cytokines 
Recombinant Murine EGF Peprotech 315-09 
Recombinant Human FGF-
basic 
Peprotech 100-18B 
Ascorbic Acid Stemcell Technologies 07157
Dibutyryl-cAMP Stemcell Technologies 73886 
DMEM/F12 Thermo Scientific 31331028
Neurobasal medium Thermo Scientific 21103049 
GMEM Thermo Scientific  
MEM Non-essential amino 
acid 
  
Sodium pyruvate  
2-mercaptoethanol   
BSA (7.5% solution) Thermo Scientific 15260037 
N-2 Supplement (100x) Thermo Scientific 17502048
B-27 Supplement (50x)  Thermo Scientific 17504044
PD0325901 Stemcell Technologies 72182
CHIR99021 Miltenyi Biotec 130-103-926 
Poly-DL-ornithine 
hydrobromide,mol wt 3,000-
15,000 
Sigma-Aldrich P8638 
Commercial Assays and Kits 
RNeasy MinElute clean-up 
kit 
Qiagen 74204 
µMacs Streptavidin Kit Miltenyi 130-074-101 
Turbo DNase Ambion   
NEBNext Ultra II Directional 
RNA Library Prep Kit for 
Illumina 
Neb E7420 
NEBNext Multiplex Oligos 
 
Neb E7335, E7500 
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Figure legends 
 
Figure 1. Generation of slow RNAPII knock-in mutant mouse ESCs.  
A Cartoon depicting the mutagenesis strategy, including the genomic target 
 locus, as well as the structure of targeting vector. Arrows indicate location of 
 primers used for genotyping.  
B Restriction enzyme diagnostic test for the presence of the R749H mutation.  
C Sequence trace of cDNA showing the presence of the heterozygous and 
 homozygous R749H mutation. 
D  qRT-PCR with primers specific to both wild-type and mutant RNAPII (left  
panel) or to the mutant form of RNAPII (right panel), confirming that only the 
 slow version of RNAPII is expressed in homozygous slow/slow ESCs. The 
sequences of the respective forward primers are shown. The “WT/slow allele” 
primer is complementary to the sequence in exon 14 upstream of the mutation. 
The “slow allele only” primer has its 3’ end matching the mutated codon 749 
and does not anneal to the WT DNA sequence. The mean ± SEM is plotted, 
n=2.  
 
Figure 2. CRISPR/Cas-mediated generation of a slow RNAPII knock-in mutant 
mouse. 
A Cartoon depicting the mutagenesis strategy, including the genomic target  locus, 
as well as two repair templates, either introducing a silent mutation (silent 
oligo) or the R749H mutation (slow oligo). Multiple repair oligo templates were 
tested with different composition of silent restriction sites.  
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B, C  Total number of WT, heterozygous and homozygous embryos (E3.5 and slow 
(R749H) RNAPII mutation or repaired with the WT sequence (silent oligo). 
Repair oligos and the stage that embryos/mice were analyzed are indicated.  
 * indicates p<0.01 (Fisher’s exact test relative to E3.5). 
 
Figure 3. Global analysis of transcription elongation rate in mouse ESCs by 4sU-
DRBseq. 
A  Schematic of the 4sU-DRB-seq labeling protocol. 
B  Meta-gene profile of normalized 4sU-DRB-seq reads in WT/WT and 
 slow/slow ESCs. 
C, D  Density and violin plot of elongation rate (bases/min) calculated for genes 
 common in all genotypes in WT/WT, WT/slow and slow/slow ESCs. Box 
 and whisker (5-95 percentile) indicates median. Mann-Whitney test, 
 ****p <0.0001. 
 
Figure 4. Differentiation of WT and slow ESCs along the neural lineage.  
A Schematic of the neural differentiation system used in this study, indicating 
the relevant markers that define different stages of differentiation. 
B  Brightfield images and analysis of NPC markers by immunofluorescence 
 staining (Sox1 and Nestin) or RT-qPCR (Nestin and Pax6) (n=3, mean 
 ±SEM). 
C  Brightfield images of aggregates. 
D  Brightfield images and immunofluorescence staining for Nestin and neuronal 
 marker Tuj1 in NSC cultures grown in EGF/FGF proliferating conditions. 
 White arrows indicate NSCs and green arrows differentiated cells. Two small 
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 panels on the right are examples of Tuj1+ neuronal cells in slow/slow NSCs 
 cultures. 
E  Immunofluorescence staining for neuronal marker Tuj1 in neuronal cultures 
grown on poly-ornithine/laminin at 21 days of differentiation.  
 
Figure 5.  The rate of transcriptional elongation influences alternative splicing 
decisions in ESCs and during neural differentiation.  
A Number of alternative splicing events that are sensitive to a slow elongation 
rate, including cassette exons, microexons, alternative 3’ or 5’ splice sites and 
retained introns in ESCs and at different stages of neural differentiation. UP 
and DOWN refers to increased or decreased levels of a splicing event in 
slow/slow cells relative to WT cells with dPSI (percent spliced in) ≥10% and 
FDR<0.05 when comparing regulated events to all detected events and 
retained (Total). Splicing was quantified using VAST-TOOLS.  
B  RT-PCR analysis validation of selected alternatively spliced exons. RT-PCR 
was performed on total RNA from WT or slow/slow ESCs, NPCs or neurons. 
PCR products were visualized and quantified by Bioanalyzer (Agilent). 
Images are representative of experiments performed in triplicate. Themean ± 
SEMis plotted with *p-value<0.05, **p<0.005, ***<0.0001 as determined by 
t-test.  
 
Figure 6. A slow RNAPII preferentially affects synaptic genes. 
A  Gene ontology analysis of genes downregulated in slow/slow neurons 
 showing the top ranked cellular component (CC), biological processes (BP) 
 or  molecular functions (MF) GO categories. 
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B  Box plot showing the length of upregulated (UP), downregulated (DOWN), 
 not affected genes (ALL), and pre-mRNAs affected by alternative splicing 
 (AE, for Alternative exons) for ESCs (left panel); length of upregulated (UP), 
 downregulated  (DOWN), not affected genes (ALL), pre-mRNAs affected by 
 alternative splicing (AE, for Alternative exons), and  not affected genes that 
 are only expressed in neurons (but not in ESCs) (ALL_notESC), for Neurons 
 (right panel). n.s., p-value>0.05, **p<0.005; ****p<0.0001 as determined by 
Mann-Whitney t-test. Boxes delimit the first and third quartiles. The 
horizontal lines represent the data medians. Whiskers are drawn down to the 
1st and 99th percentile.  
 
C Percentage of genes that are downregulated in ESCs and neurons; plotted as a 
sliding window of 100 genes by length.  
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Legends for Expanded view Figures 
 
Figure EV1, Validation of the transcriptional elongation rate in ES mutant cell 
lines (related to Fig 3). 
A Cartoon depicting the structure of Itpr1 and Utrophin pre-mRNAs, with 
primer pairs selected to monitor the appearance of selected intron-exon 
junctions indicated by arrows. Quantification of pre-mRNA at different time 
points at the beginning, in the middle and at the end of the gene displayed 
relative to cells not treated with DRB in WT/WT, WT/slow and slow/slow 
cells (black,  grey and purple bars, respectively). The mean ± SEM is 
shown, n=3. 
B Time course of incorporation of 3H-uridine in WT/WT or slow/slow cells. 
 Time 0’ corresponds to time of DRB wash-off. Mean ± SEM is plotted with 
 *p<0.05 as determined by t-test, n=3 
C  In vitro transcription of a linearized plasmid using nuclear extracts from either 
WT/WT or slow/slow ES cells. The image shown is representative of 1 of 2 
reproducible experiments. 
 
Figure EV2, Analysis of elongation rate in mouse ESCs by 4sU-DRBseq (related 
to Fig. 3).  
A  Example of wave progression in the Notch1 gene (reverse strand) following 
 release from DRB block at 0, 5 and 15 min.  
B  Position of the 4sU-DRB-seq transcription wave-front for common genes 
 over time. Dashed lines indicate median wave-front positions.  
                                                                                                              Maslon et al. 
 45
C Correlation of elongation rate measured in WT/WT, WT/slow and slow/slow 
ESCs with mean expression. Correlation coefficients are 0.047, 0.003 and 
0.015 (p=2.1e-10, 0.036 and 9.4e-8), respectively. 
 
Figure EV3, Characterization of WT and slow ESCs differentiated to neurons 
(related to Fig. 4). 
A  Immunofluorescence staining for neuronal markers Map2, Syn1 and NeuN in 
neurons cultured on poly-ornithine/laminin-coated plates. 
B  Expression of neuronal markers in neurons cultured on poly-ornithine/laminin-
coated plates from RNA-seq analysis, n=3 
 
Figure EV4, Characterization of mRNAs differentially spliced in slow/slow cells. 
(related to Fig. 5). 
A  Length of alternative exons and flanking introns in ESCs and neurons. Boxes 
delimit the first and third quartiles. The horizontal line represents the data 
medians. Whiskers are drawn down to the 5th and the 95th percentile . Mann-
Whitney test, p < 0.01 (*), 0.001 (**), 0.0001 (***).  
 
B  Example of RNA maps produced using matt for Nova1 and Fox for exons  more 
included (blue) or less included (red) or unchanged (grey) in neurons,  bold line 
represents p<0.1. These maps reveal increased binding of these  factors 
downstream of the regulated exon 
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Figure EV5, Correlation between gene expression and AS changes between WT 
and slow/slow cells (related to Fig. 5). 
(A-C) Correlation between changes in AS (cassette exons, microexons and intron 
retention events), and gene expression in slow/slow cells, as compared to ESCs (A), 
NPCs (B) and neurons (C).  The y-axis shows dPSI, which represents the difference in 
percent splicing inclusion between slow/slow and WT cells, while the x-axis 
represents a log2-fold change in expression between slow/slow and WT cells. Blue 
dots are for genes that change in expression (Changed DE), red dots are for 
differentially spliced pre-mRNAs (Changed AS), and purple dots represent both 
differentially expressed and spliced genes. The relation between these two variables is 
represented by the regression line correlation coefficients r2. 
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